GRIDD Phase 3 – Patient Data Verification Delphi – Help grow your organization’s evidence-based messaging
The Global Research on the Impact of Dermatological Diseases (GRIDD) project is now officially in Phase 3 and focused on a Patient Data Verification Delphi. This process will help us be certain that the issues our researchers have collected thus far from patients globally are truly accurate and are being communicated in a way that makes sense to patients.
The primary goal of the Delphi is to gather data from 2000 dermatology patients representing as many different dermatological diseases as possible and from all regions of the globe. The two-step survey process will take place starting in October. The surveys will be available in English, French, Spanish, Mandarin (simplified Chinese), and Arabic.
By being part of the Phase 3 – Patient Data Verification Delphi, your organization will be able to leverage new scientifically-validated research and supportive programming that can help grow your organization’s evidence-based messaging about your disease.
We welcome everyone who lives with a dermatological disease or condition to be a participant for the GRIDD Patient Data Verification Delphi. Your support is vital to the success of the GRIDD research project.
Watch for GlobalSkin’s invitation in your inbox in early October.